Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Power production in February 38.9 GWh

Better wind conditions than normal in February resultated in a power production of 38.9 GWh, compared to the month’s budget of 29.9 GWh. Halmstad, 8 March 2022 ARISE AB (publ) For further information, please contact: Per-Erik Eriksson, CEO Arise AB, +46 702 409 902 This information is information that Arise AB is obliged to make public pursuant to the EU MarketAbuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 09.05 CET on 8 March, 2022. Regarding information about how we process your personal data we

Metso Outotec acts upon unexplained gender-related pay gaps during 2022

Metso Outotec Corporation’s press release on March 8, 2022, at 10:00 a.m. EETMetso Outotec is committed to developing the company into a workplace where diversity and inclusion is embedded into the culture, and it is fostered and promoted. One concrete action is to ensure global fair pay practices. For this, Metso Outotec initiated a global fair pay analysis in 2021 with a technical data analysis, followed by a thorough review of the findings. The analysis is still partly ongoing. The study has been conducted together with an external partner who has extensive expertise in the field. In

Observe Medical completes acquisition of Biim Ultrasound and issues consideration shares

Oslo, 8 March 2022: Observe Medical ASA (OSE: OBSRV) (the "Company" or Observe Medical") is excited to announce the completion of the acquisition of Biim Ultrasound AS ("Biim Ultrasound"), an international medical ultrasound technology company, adding another innovative product that improves patient welfare and outcome and that promotes positive health economics to its portfolio. With this acquisition, Observe Medical also significantly strengthens and broadens its distribution network into the US. This combined expansion of product range and distribution capacity are important steps

BioStock: Curasight expands its clinical portfolio

Several investigator-initiated trials have lately shown great results for Curasight’s PET tracer uTRACE, strengthening the company´s uPAR approach to cancer diagnostics. Following the positive results seen in neuroendocrine tumours and head and neck cancer, the Danish biotech has decided to expand its clinical portfolio with the two indications. BioStock has contacted CEO Ulrich Krasilnikoff to learn more.Read the full article at biostock.se:https://www.biostock.se/en/2022/03/curasight-expands-its-clinical-portfolio/This is a press release from BioStock - Connecting Innovation & Capital.

2020 Bulkers Ltd. (2020) – Annual Report 2021

Hamilton, Bermuda, March 8, 2022 2020 Bulkers Ltd. announces that the Annual Report for the year ended December 31, 2021 has been approved by the Board of Directors of the Company. There were no changes to the consolidated statements of operations or consolidated balance sheets compared to those presented on January 26, 2022. The Annual Report for 2021 will be published on March 10, 2022. About 2020 Bulkers Ltd.: 2020 Bulkers has eight Newcastlemax dry bulk vessels in operation. All vessels are fitted with exhaust scrubber systems.

The last day of trading for the warrants of series TO1 in Veg of Lund AB (publ) is today, 8 March 2022

Today, 8 March 2022, is the last day of trading with the warrants of series TO1 (“Warrants”) in Veg of Lund AB (publ) (“Veg of Lund” or the “Company”). The exercise period for the Warrant runs up to and including 10 March 2022. Each Warrant entitles the holder to subscribe for one (1) new share in the Company at a price of SEK 11.06 per share.Summarized terms for the Warrants:Exercise period: 25 February 2022–10 March 2022. Subscription price: SEK 11.06 per share. Volume: 784,619 Warrants. If all Warrants are exercised, 784,619 shares are issued, and the Company can receive, at most,

Change in Kamux’s Management Team: Mikko-Heikki Inkeroinen to take up new responsibilities outside Kamux

Kamux Corporation       Stock Exchange Release     March 8, 2022 at 09:30 (EET)       Change in Kamux’s Management Team: Mikko-Heikki Inkeroinen to take up new responsibilities outside Kamux Mikko-Heikki Inkeroinen, Kamux’s CDO and Member of the Management Team, has decided to leave to take up new responsibilities outside the company. He will continue in his current position until May 15, 2022. “I would like to express my warmest thanks to Mikki for his contribution to the company's digital development and marketing. I wish Mikki all the best in his future tasks,” CEO Juha

Mandatory notification of trade

Anooj Unarket, Board member of Otello Corporation ASA, has on behalf of certain related parties, as of 7th March 2022, acquired interests in shares of Otello Corporation ASA. The balance of Anooj Unarket and related parties’ holdings after the transaction totals 27,305,769 shares.  Please refer to the attached notification of trading for further details. This information is subject to disclosure requirements in regulation EU 596/2014 article 19 number 3 and the Norwegian Securities Trading Act section 5-12.

Cessatech reports successful outcome of bioavailability trial 0204 with CT001

Topline results of clinical trial 0204 investigating the absolute bioavailability of CT001 showed clinical relevant exposures following nasal administration. Primary aim of the trial was to investigate drug-exposure following nasal administration of CT001 relative to the IV injection of the approved drug counterparts.Cessatech A/S announces topline results of its Phase 1 bioavailability trial (0204) with CT001 in healthy adults (NCT04807335).  In this randomised, three-treatment, three-period, single dose crossover trial 15 healthy subjects were allocated to treatment with CT001, IV

Valmet launches the Beyond Circularity project to boost green transition

Valmet Oyj’s press release March 8, 2022 at 9:30 a.m. EETValmet will launch a new R&D and innovation project called Beyond Circularity, which improves Valmet’s readiness to support the green transition in Valmet’s customer industries based on the company’s technology vision 2030. The project aims at further strengthening Valmet’s R&D work in order to develop process technologies, automation and services for utilizing renewable materials and recycled, waste and side streams. The project also allows Valmet to further improve the energy efficiency of its process technologies and enable a shift

Swedbank’s Green Bond Impact Report 2021

Swedbank’s Green Asset Register increased by SEK 26.3 billion during 2021, to SEK 44.7 billion. The increase enabled Swedbank to issue three green bonds during the year and the bank now has outstanding green bonds in all major currencies: EUR, USD and GBP, as well as in SEK.Swedbank targets and supports financing in sectors that are adapting to a more sustainable society. Green financing enables Swedbank to meet our customers’ growing demand and need for green loans. It also contributes to the realisation of Swedbank’s strategy. Swedbank is committed to directly transferring back to the

Rejlers broadens cooperation with Finland's transmission system operator Fingrid

Rejlers is broadening its cooperation with Fingrid and has now been approved as a supplier of consulting services for the general planning of transmission lines. Fingrid is Finland's transmission system operator, responsible for the functioning of the nationwide main grid."Becoming a supplier to Fingrid is a milestone on our journey in transmission line design. This shows that we have achieved a high quality and competence in the field," says Matti Hautero, Service Manager at Rejlers in Finland. Fingrid is considered one of the most demanding customers in the electricity sector in

Scandinavian ChemoTech AB (publ) Year-End Report January – December 2021 - Executive Summary

Fourth quarter · Net sales amounted to kSEK 10 (0) · Profit before tax amounted to kSEK -5 430 (-2 792) · Earnings per share amounted to SEK -0,56 (-0,46) · Cash flow from operating activities totaled to kSEK -5 755 (-2 794)       Period 1 January - 31 December · Net sales amounted to kSEK 49 (131) · Profit before tax amounted to kSEK -17 743 (-11 664) · Earnings per share amounted to SEK -2,05 (-2,37) · Cash flow from operating activities totaled to kSEK -19 183 (-11 495) · The order book amounted to kSEK 1 100 at the end of the period        Important

EQT Future to invest in SNFL and IFG, two innovators in fruit genetics

· EQT Future to make a significant minority investment in the combination of SNFL and IFG, two innovators in table grape and cherry breeding, with the ambition to form a company with an improved value proposition for growers, retailers and consumers · SNFL and IFG develop improved fruit varieties (table grapes and cherries) through natural hybridization and other non-GMO processes. The enhanced genetics improve fruits’ agricultural yield, nutritional value, taste, crunchiness and shelf life · In accordance with EQT Future’s impact-driven strategy, EQT will support the development of

2020 Bulkers Ltd. (2020) – Commercial update and key information relating to the cash distribution for February 2022

Hamilton, Bermuda, March 8, 2022   Commercial update:   In February 2022, the Company achieved average time charter equivalent earnings of approximately US$23,800 per day, gross. The Company’s six vessels trading on index-linked time charter earned approximately US$19,800 per day, gross, including average daily scrubber benefits of approximately US$2,300 per day. The Company’s two vessels trading on fixed time charter earned approximately US$35,800 per day, gross, including average daily scrubber benefits of approximately US$4,000 per day.   The Baltic 5TC Capesize Index

Teknos suspends its operations in Russia

At Teknos, we are shocked and heartbroken about the war in Ukraine. Our minds and hearts are with all the people affected by the war, either directly or indirectly. Teknos is a Finnish family-owned company, but we operate globally, also in Ukraine and Russia.  “Our top priority is the safety and wellbeing of all our employees and their families in Ukraine and do our outmost to help them. As a company, we condemn the Russian war and stand fully behind all the sanctions imposed. As part of our actions of solidarity with Ukraine, we suspend our operations in Russia. Due to the hostilities,

All set for construction of Halvorsäng Logistics Park in Sweden’s leading logistics city

It’s springtime for Gothenburg as Scandinavia's leading logistics city. The City Council has approved Castellum's and the Port of Gothenburg's joint venture, and the symbolic first shovel sod will soon mark the start of constructions at Halvorsäng Logistics Park, consisting of 270,000 square meters of logistics land."Both the location and the conditions are perfect for achieving something really extra that will benefit Gothenburg's competitiveness while also creating new jobs in the region," says Mariette Hilmersson, CEO of Castellum’s Region West.After carefully evaluating the Halvorsäng

Herantis Pharma to Participate in the Upcoming Investor and Partnering Conference

Herantis Pharma Plc, Press Release, 8 March 2022 at 09:00 EET Herantis Pharma Plc (“Herantis”), developing disease modifying therapies for Parkinson’s disease, today announced that Antti Vuolanto, Chief Operating Officer, will hold a company presentation at: Sachs 5th Annual Neuroscience Innovation Forum (Virtual) The presentation will be held on March 22, 2022 1x1 meetings will be scheduled with the management team during March 21 – 25, 2022 The presentation will be available via a digital library, which is accessible to event participants only. Please contact the conference

SCA publishes 2021 annual and sustainability report

SCA today publishes its annual and sustainability report for 2021. In the report, SCA describes the company's work to contribute to a fossil-free society. SCA's climate benefit in 2021 amounted to 10.5 million tonnes of carbon dioxide based on the forest's net carbon sequestration, substitution effect and reduced fossil emissions.The annual report is available on the SCA website at www.sca.com. The printed annual report will begin to be distributed to shareholders and other stakeholders from March 25 2022. The annual report is published in accordance with the reporting requirements of

AFRY will establish a production facility in Sweden for Hooked Foods in less than a year

AFRY is now part of Hooked Foods’ journey, supporting with the process design, food safety, supply chain, automation strategy and facility requirements. AFRY will realise expansion plans to establish a Swedish production facility in less than a year. AFRYs role will be to support and advise Hooked Foods in their work of developing a new pilot plant in Sweden.Hooked Foods is an impact driven startup committed to solving large scale environmental problems and develop plant-based seafood to lead the transition to a healthier marine ecosystem. The company recently ranked 236 on the Global

Vestas secures first EnVentus order in Portugal

News release from Vestas MediterraneanMadrid, 8 March 2022 Vestas has received a 42 MW order for several wind parks in Portugal. The contract includes the supply and installation of two V162-6.2 MW, two V117-4.2 MW and six V126-3.45 MW wind turbines in 3.6 MW operating mode, as well as a 15-year Active Output Management 5000 (AOM 5000) service agreement. “We are glad to see the first EnVentus order in Portugal. The V162-6.2 MW delivers industry-leading energy production and we expect our technology to make a significant contribution to the energy transition in the region. This order

Catena Media announces outcome of warrants exercised post-Q4 2021 report subscription period

Catena Media plc (“Catena Media” or the “company”) today announces the outcome of the subscription period following the publication of the interim report for the fourth quarter of 2021 (“subscription period”) of the warrants 2020/2024 (“warrants”) issued as part of the rights issue of units. Exercise of warrantsA total of 135,147 warrants, corresponding to approximately 0.4 percent of all outstanding warrants (being approximately 0.3 percent of all warrants issued as part of the rights issue), were used to subscribe for the same number of new ordinary shares in the company. The

Finnair Traffic Performance in February 2022

Finnair Plc                Investor News              8 March 2022 at 9:00 a.m. EET Clear improvement in passenger traffic figures year-on-year, but figures remained close to January 2022 levels due to the Omicron impact; strong cargo performance continued In February, Finnair carried 443,000 passengers, which was 407.5% more than in February 2021. The number of passengers in February 2022 was 1.8% less than in January 2022 (month-on-month figures are not fully comparable as there were three fewer days in February). The COVID-19 impact, including the strict travel restrictions

There are no items matching the current filter
There are no more items matching the current filter
Back to top